The “EU‐Japan Cluster Matchmaking Event” was held at BIO‐Europe in Frankfurt, Germany, on 3rd November, 2014. Leading Japanese health care cluster representatives and their European counterparts met at this event to begin to build bridges between their organisations and to path the way for potential collaborations –as part of their goal to help SMEs find business partners. Continue reading
The bioXclusters partners, along with some European SMEs, visited Boston (Massachusetts) in October 2013. Read this interesting report that includes the description of the visit and information about the life sciences market in this country.
The bioXclusters partners, along with some European SMEs, visited Shanghai in May 2013. Read the report about the mission which includes descriptions of the visits made and information about life sciences in this exciting and fast growing market.
Until recently, the history of the pharmaceutical industry in China was more about imitation than innovation.
According to a report by London-based market researcher Scrip Intelligence, approximately 40% of biotech sales in China come from biosimilars. This would explain why the market for biologics in China has been growing at a rate of more than 25% a year, while total sales of biotech drugs are still only $1.5 billion a year. Read more
This report is a compilation of information about the Chinese life sciences market. It pools information from a variety of different sources and contains practical tips, an overview of the sector and details opportunities that exist in this country. Open the report in the Docs&Resources section
Click here to access the updated report published by BayBio, PWC & CHI.